Association between mean platelet volume and adiponectin in patients with metabolic syndrome

Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated. The aim of our study was to investigate the asso...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of applied biomedicine Ročník 22; číslo 4; s. 208 - 213
Hlavní autoři: Marinkovic, Milos, Nesic, Jelena, Petrovic, Ivica, Jovanovic, Ivan P, Sekulic, Marija, Djukic, Svetlana, Djukic, Aleksandar
Médium: Journal Article
Jazyk:angličtina
Vydáno: Poland 01.12.2024
Témata:
ISSN:1214-021X, 1214-0287, 1214-0287
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated. The aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome. The investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio. The subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association. Considering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective.
AbstractList Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated.BACKGROUNDMetabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated.The aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome.OBJECTIVEThe aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome.The investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio.METHODSThe investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio.The subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association.RESULTSThe subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association.Considering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective.CONCLUSIONConsidering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective.
Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated. The aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome. The investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio. The subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association. Considering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective.
Author Djukic, Svetlana
Djukic, Aleksandar
Sekulic, Marija
Nesic, Jelena
Marinkovic, Milos
Petrovic, Ivica
Jovanovic, Ivan P
Author_xml – sequence: 1
  givenname: Milos
  surname: Marinkovic
  fullname: Marinkovic, Milos
– sequence: 2
  givenname: Jelena
  surname: Nesic
  fullname: Nesic, Jelena
– sequence: 3
  givenname: Ivica
  surname: Petrovic
  fullname: Petrovic, Ivica
– sequence: 4
  givenname: Ivan P
  surname: Jovanovic
  fullname: Jovanovic, Ivan P
– sequence: 5
  givenname: Marija
  surname: Sekulic
  fullname: Sekulic, Marija
– sequence: 6
  givenname: Svetlana
  surname: Djukic
  fullname: Djukic, Svetlana
– sequence: 7
  givenname: Aleksandar
  surname: Djukic
  fullname: Djukic, Aleksandar
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40033808$$D View this record in MEDLINE/PubMed
BookMark eNo9kEtLAzEURoNU7EOXbiVLN1PzmEeyLMUXFNwouBCGJHMHp8wk4yRj6b832lq48N3F-e6FM0cT6ywgdE3JkrOCZXdbpZeMsHRJGDtDM8pomhAmislpp-9TNPd-S0iWy4JdoGlKCOeCiBn6WHnvTKNC4yzWEHYAFnegLO5bFaCFgL9dO3aAla2wqpo-vjehsThOH2tgg8e7JnzGVlDatY3Bfm-rwXVwic5r1Xq4OuYCvT3cv66fks3L4_N6tUkMEyIkRgupci6lruua5XmuheBZpQVnoKUplKC1oEYIBSITuZKRIEZKniujWEH5At0e7vaD-xrBh7JrvIG2VRbc6EtOC56SImM8ojdHdNQdVGU_NJ0a9uW_kQgkB8AMzvsB6hNCSflnvIzGy1_jZTTOfwC1XnRG
Cites_doi 10.1177/107602960601200203
10.1016/j.biochi.2012.06.008
10.2337/db09-1008
10.1111/j.1538-7836.2008.02982.x
10.3390/jcm12010132
10.1007/s11906-018-0812-z
10.3390/nu13041180
10.1210/er.2008-0024
10.1002/rth2.12266
10.1016/j.metabol.2008.06.008
10.1080/09537104.2016.1224828
10.1536/ihj.48.149
10.1016/j.atherosclerosis.2005.10.034
10.4103/ijpvm.IJPVM_193_20
10.1016/j.heliyon.2023.e21983
10.1007/s00296-019-04349-x
10.1002/dmrr.3403
10.1016/j.atherosclerosis.2020.04.018
10.1038/s41574-019-0230-6
10.1111/j.1464-5491.2006.01858.x
10.1016/j.ecl.2004.03.008
10.1161/01.ATV.0000099786.99623.EF
10.1161/01.ATV.0000194076.84568.81
10.3390/ijms20051190
10.1182/bloodadvances.2021006680
10.2147/VHRM.S48753
10.1016/j.atherosclerosis.2012.12.012
10.1155/2019/9213074
10.1038/s41401-022-00943-1
10.4049/jimmunol.1900899
10.1007/s10557-022-07325-z
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.32725/jab.2024.022
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1214-0287
EndPage 213
ExternalDocumentID 40033808
10_32725_jab_2024_022
Genre Journal Article
GrantInformation_xml – fundername: Faculty of Medical Sciences, the University of Kragujevac
  grantid: JP 01/23
GroupedDBID ---
--M
.~1
0R~
1~.
29J
2WC
4.4
457
4G.
53G
5GY
7-5
8P~
AAEDT
AAIKJ
AAOAW
AAXLA
AAYXX
ABDBF
ABGSF
ABMZM
ACGFS
ACUHS
ADBBV
ADEZE
AEKER
AENEX
AGHFR
AGUBO
AJRQY
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BLXMC
CITATION
DIK
E0C
E3Z
EBD
ECGQY
EN8
ESX
F5P
FDB
FIRID
FNPLU
FRP
GBLVA
GROUPED_DOAJ
ML~
OAUVE
OK1
OVT
P-8
P-9
P2P
P6G
PC.
SA.
TR2
~8M
9-L
AALRI
AAXUO
ABXDB
ACRPL
ADNMO
ADUQZ
AFSHE
AGGNV
AITUG
ANZVX
CGR
CUY
CVF
EBS
ECM
EIF
EJD
FEDTE
HVGLF
MET
NPM
ROL
~Z8
7X8
ID FETCH-LOGICAL-c288t-cb89a6399bfff2666b8835db832eb9c7a81f81c88ae8586a966b0c9936aca2713
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001361565700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1214-021X
1214-0287
IngestDate Sun Sep 28 03:08:00 EDT 2025
Mon May 12 02:38:51 EDT 2025
Sat Nov 29 07:52:00 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Mean platelet volume
Metabolic syndrome
Platelets
Adiponectin
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c288t-cb89a6399bfff2666b8835db832eb9c7a81f81c88ae8586a966b0c9936aca2713
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://jab.zsf.jcu.cz/doi/10.32725/jab.2024.022.pdf
PMID 40033808
PQID 3173407523
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_3173407523
pubmed_primary_40033808
crossref_primary_10_32725_jab_2024_022
PublicationCentury 2000
PublicationDate 2024-Dec
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-Dec
PublicationDecade 2020
PublicationPlace Poland
PublicationPlace_xml – name: Poland
PublicationTitle Journal of applied biomedicine
PublicationTitleAlternate J Appl Biomed
PublicationYear 2024
References ref13
ref12
ref15
ref14
ref30
ref11
ref10
ref0
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref6
  doi: 10.1177/107602960601200203
– ident: ref20
  doi: 10.1016/j.biochi.2012.06.008
– ident: ref7
  doi: 10.2337/db09-1008
– ident: ref24
  doi: 10.1111/j.1538-7836.2008.02982.x
– ident: ref17
  doi: 10.3390/jcm12010132
– ident: ref25
  doi: 10.1007/s11906-018-0812-z
– ident: ref12
  doi: 10.3390/nu13041180
– ident: ref3
  doi: 10.1210/er.2008-0024
– ident: ref23
  doi: 10.1002/rth2.12266
– ident: ref14
  doi: 10.1016/j.metabol.2008.06.008
– ident: ref19
  doi: 10.1080/09537104.2016.1224828
– ident: ref8
  doi: 10.1536/ihj.48.149
– ident: ref28
  doi: 10.1016/j.atherosclerosis.2005.10.034
– ident: ref18
  doi: 10.4103/ijpvm.IJPVM_193_20
– ident: ref2
  doi: 10.1016/j.heliyon.2023.e21983
– ident: ref1
  doi: 10.1007/s00296-019-04349-x
– ident: ref10
  doi: 10.1002/dmrr.3403
– ident: ref27
  doi: 10.1016/j.atherosclerosis.2020.04.018
– ident: ref26
  doi: 10.1038/s41574-019-0230-6
– ident: ref0
  doi: 10.1111/j.1464-5491.2006.01858.x
– ident: ref4
  doi: 10.1016/j.ecl.2004.03.008
– ident: ref16
  doi: 10.1161/01.ATV.0000099786.99623.EF
– ident: ref11
  doi: 10.1161/01.ATV.0000194076.84568.81
– ident: ref29
  doi: 10.3390/ijms20051190
– ident: ref9
  doi: 10.1182/bloodadvances.2021006680
– ident: ref5
  doi: 10.2147/VHRM.S48753
– ident: ref21
  doi: 10.1016/j.atherosclerosis.2012.12.012
– ident: ref13
  doi: 10.1155/2019/9213074
– ident: ref30
  doi: 10.1038/s41401-022-00943-1
– ident: ref15
  doi: 10.4049/jimmunol.1900899
– ident: ref22
  doi: 10.1007/s10557-022-07325-z
SSID ssj0056972
Score 2.3230426
Snippet Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule,...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 208
SubjectTerms Adiponectin - blood
Adult
Blood Platelets - metabolism
Blood Platelets - pathology
Case-Control Studies
Cross-Sectional Studies
Female
Humans
Male
Mean Platelet Volume
Metabolic Syndrome - blood
Middle Aged
Title Association between mean platelet volume and adiponectin in patients with metabolic syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/40033808
https://www.proquest.com/docview/3173407523
Volume 22
WOSCitedRecordID wos001361565700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1214-0287
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0056972
  issn: 1214-021X
  databaseCode: DOA
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb9MwGP3UDTTtMvGbDpiMhLigjMZJY_uIEAgmVnEYqAekyHYSaaNNojarduU_57Mdpx4wCQ5IVVTZjV197-nl2bE_A7yYTFWSJmwS0QLHqinjKhIFKyJdxWqaaVEpO5X99RObzfh8Lj6PRj_8XpjNgtU1v7oS7X-FGssQbLN19h_gHhrFAvyOoOMVYcfrXwEfBHxYhbU08-3tAn0lwvTKKZJL01qct01tRM-ueOyzrPZb3pZlhxQxWbD_lNcgsLLSW1m7l__au_pTHIvX3xvUI7dIf9EMJn5Wrl3piXn0ya1Idyv_-4-bYCnRSYOuf1tj1Ducs6BpsP6jdDpL4zRCa8NCIaY0IFwaqqpN_fCb2ieU2bObLqQ6Nr0cT1wLAcjt0qKcmiPruGvll_TavmoHblE2FcKPyt3DfJoJRl1qVtvb67Cvfdjzd193NTcMVaxlObsDBz1A5I3jyF0YlfU92DvtEboP3wKqkJ4qxFCFeKoQFzOCVCEBVQh-PFWIoQoZqEI8VR7Al_fvzt5-iPrTNiJNOe8irbiQxq-qqqrQtmWKozsvFEp-qYRmkscVjzXnsuRTnkkcJ6uJRnubSS0pi5OHsFvj33gMBF1zlipaJTEKgWJKFQpvEibdnNZxEY_hpY9W3rqkKjkORm2Ec4xwbiKcY4TH8NzHMkfZM--yZF02l-scbW-Sot2lyRgeuSAPTXlQDm-seQL7W1o-hd1udVk-g9t6052vV0eww-b8yPLgJ7_cgYQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+mean+platelet+volume+and+adiponectin+in+patients+with+metabolic+syndrome&rft.jtitle=Journal+of+applied+biomedicine&rft.au=Marinkovic%2C+Milos&rft.au=Nesic%2C+Jelena&rft.au=Petrovic%2C+Ivica&rft.au=Jovanovic%2C+Ivan+P&rft.date=2024-12-01&rft.eissn=1214-0287&rft.volume=22&rft.issue=4&rft.spage=208&rft_id=info:doi/10.32725%2Fjab.2024.022&rft_id=info%3Apmid%2F40033808&rft.externalDocID=40033808
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1214-021X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1214-021X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1214-021X&client=summon